Yvonne Mcgrath - Net Worth and Insider Trading

Yvonne Mcgrath Net Worth

The estimated net worth of Yvonne Mcgrath is at least $0 dollars as of 2024-09-20. Yvonne Mcgrath is the Chief Scientific Officer of ITeos Therapeutics Inc and owns about 0 shares of ITeos Therapeutics Inc (ITOS) stock worth over $0. Details can be seen in Yvonne Mcgrath's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yvonne Mcgrath has not made any transactions after 2022-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Yvonne Mcgrath

To

Yvonne Mcgrath Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yvonne Mcgrath owns 1 companies in total, including ITeos Therapeutics Inc (ITOS) .

Click here to see the complete history of Yvonne Mcgrath’s form 4 insider trades.

Insider Ownership Summary of Yvonne Mcgrath

Ticker Comapny Transaction Date Type of Owner
ITOS ITeos Therapeutics Inc 2022-03-01 VP & Research and Development

Yvonne Mcgrath Latest Holdings Summary

Yvonne Mcgrath currently owns a total of 1 stock. Yvonne Mcgrath owns 0 shares of ITeos Therapeutics Inc (ITOS) as of March 1, 2022, with a value of $0.

Latest Holdings of Yvonne Mcgrath

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ITOS ITeos Therapeutics Inc 2022-03-01 0 11.05 0

Holding Weightings of Yvonne Mcgrath


Yvonne Mcgrath Form 4 Trading Tracker

According to the SEC Form 4 filings, Yvonne Mcgrath has made a total of 3 transactions in ITeos Therapeutics Inc (ITOS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in ITeos Therapeutics Inc is the sale of 10,000 shares on March 1, 2022, which brought Yvonne Mcgrath around $367,600.

Insider Trading History of Yvonne Mcgrath

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yvonne Mcgrath Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Yvonne Mcgrath Ownership Network

Ownership Network List of Yvonne Mcgrath

No Data

Ownership Network Relation of Yvonne Mcgrath

Insider Network Chart

Yvonne Mcgrath Owned Company Details

What does ITeos Therapeutics Inc do?

Who are the key executives at ITeos Therapeutics Inc?

Yvonne Mcgrath is the VP & Research and Development of ITeos Therapeutics Inc. Other key executives at ITeos Therapeutics Inc include Chief Financial Officer Matthew Gall , other: See remarks Aaron I. Davis , and other: See remarks Boxer Capital, Llc .

ITeos Therapeutics Inc (ITOS) Insider Trades Summary

Over the past 18 months, Yvonne Mcgrath made no insider transaction in ITeos Therapeutics Inc (ITOS). Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net sale of 350,000 shares made by Boxer Capital, Llc , and a net purchase of 5,000 shares made by Matthew Gall .

In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 350,000 shares of ITeos Therapeutics Inc (ITOS) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 345,000 shares.

ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ITeos Therapeutics Inc Insider Transactions

No Available Data

Yvonne Mcgrath Mailing Address

Above is the net worth, insider trading, and ownership report for Yvonne Mcgrath. You might contact Yvonne Mcgrath via mailing address: C/o Iteos Therapeutics, Inc., 139 Main Street, Cambridge Ma 02142.

Discussions on Yvonne Mcgrath

No discussions yet.